Compare Pfizer with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs AJANTA PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER AJANTA PHARMA PFIZER/
AJANTA PHARMA
 
P/E (TTM) x 49.2 27.9 176.2% View Chart
P/BV x 8.2 7.8 105.3% View Chart
Dividend Yield % 0.4 0.5 92.1%  

Financials

 PFIZER   AJANTA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
AJANTA PHARMA
Mar-19
PFIZER/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,8401,422 270.1%   
Low Rs2,080898 231.7%   
Sales per share (Unadj.) Rs455.0233.5 194.8%  
Earnings per share (Unadj.) Rs93.844.0 213.3%  
Cash flow per share (Unadj.) Rs109.452.2 209.7%  
Dividends per share (Unadj.) Rs22.509.00 250.0%  
Dividend yield (eoy) %0.80.8 98.0%  
Book value per share (Unadj.) Rs658.2255.1 258.0%  
Shares outstanding (eoy) m45.7588.02 52.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x6.55.0 131.0%   
Avg P/E ratio x31.626.4 119.6%  
P/CF ratio (eoy) x27.122.2 121.7%  
Price / Book Value ratio x4.54.5 98.9%  
Dividend payout %24.020.5 117.2%   
Avg Mkt Cap Rs m135,420102,081 132.7%   
No. of employees `0002.66.8 38.7%   
Total wages/salary Rs m3,2384,307 75.2%   
Avg. sales/employee Rs Th7,911.43,022.6 261.7%   
Avg. wages/employee Rs Th1,230.9633.4 194.3%   
Avg. net profit/employee Rs Th1,630.7569.1 286.6%   
INCOME DATA
Net Sales Rs m20,81520,554 101.3%  
Other income Rs m1,674211 794.1%   
Total revenues Rs m22,48920,765 108.3%   
Gross profit Rs m5,7125,664 100.8%  
Depreciation Rs m714721 99.0%   
Interest Rs m7312 628.4%   
Profit before tax Rs m6,5995,143 128.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3091,273 181.4%   
Profit after tax Rs m4,2913,870 110.9%  
Gross profit margin %27.427.6 99.6%  
Effective tax rate %35.024.8 141.3%   
Net profit margin %20.618.8 109.5%  
BALANCE SHEET DATA
Current assets Rs m27,16711,812 230.0%   
Current liabilities Rs m8,9173,776 236.1%   
Net working cap to sales %87.739.1 224.3%  
Current ratio x3.03.1 97.4%  
Inventory Days Days6877 87.6%  
Debtors Days Days3082 36.9%  
Net fixed assets Rs m8,86214,398 61.5%   
Share capital Rs m458175 260.8%   
"Free" reserves Rs m29,65622,277 133.1%   
Net worth Rs m30,11322,452 134.1%   
Long term debt Rs m257 378.8%   
Total assets Rs m39,40026,962 146.1%  
Interest coverage x91.5444.3 20.6%   
Debt to equity ratio x00 282.4%  
Sales to assets ratio x0.50.8 69.3%   
Return on assets %11.114.4 76.9%  
Return on equity %14.217.2 82.7%  
Return on capital %22.123.0 96.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42810,682 4.0%   
Fx outflow Rs m7862,102 37.4%   
Net fx Rs m-3588,580 -4.2%   
CASH FLOW
From Operations Rs m9783,748 26.1%  
From Investments Rs m351-2,228 -15.8%  
From Financial Activity Rs m-1,099-1,475 74.5%  
Net Cashflow Rs m23145 510.6%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 1.6 483.9%  
FIIs % 4.9 7.6 64.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.0 139.4%  
Shareholders   85,207 20,968 406.4%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DR. REDDYS LAB  IPCA LABS  NATCO PHARMA  NEULAND LABS  PIRAMAL ENTERPRISES  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Dips 300 Points, Nifty Falls Below 14,800; Godrej Consumer Zooms 10%(09:30 am)

Asian share markets fell for a second straight session today to one-month lows as investors speculated surging commodity prices.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 12, 2021 12:27 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS